Ceriello A - Search Results

1

Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes.

Ceriello A, Novials A, Ortega E, Canivell S, La Sala L, Pujadas G, Esposito K, Giugliano D, Genovese S. Ceriello A, et al. Diabetes Care. 2013 Aug;36(8):2346-50. doi: 10.2337/dc12-2469. Epub 2013 Apr 5. Diabetes Care. 2013. PMID: 23564922 Free PMC article. Clinical Trial.

2

Nicardipine does not cause deterioration of glucose homoeostasis in man: a placebo controlled study in elderly hypertensives with and without diabetes mellitus.

Giugliano D, Saccomanno F, Paolisso G, Ceriello A, Torella R, Varricchio M, D'Onofrio F. Giugliano D, et al. Among authors: ceriello a. Eur J Clin Pharmacol. 1992;43(1):39-45. doi: 10.1007/BF02280752. Eur J Clin Pharmacol. 1992. PMID: 1505607 Clinical Trial.

3

New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications.

Ceriello A, Quatraro A, Giugliano D. Ceriello A, et al. Diabet Med. 1992 Apr;9(3):297-9. doi: 10.1111/j.1464-5491.1992.tb01783.x. Diabet Med. 1992. PMID: 1576819 Review.

4

Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications?

Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ. Ceriello A, et al. Diabetes Care. 1991 Jan;14(1):68-72. doi: 10.2337/diacare.14.1.68. Diabetes Care. 1991. PMID: 1991440 Clinical Trial.

5

Possible role for increased C4b-binding-protein level in acquired protein S deficiency in type I diabetes.

Ceriello A, Giugliano D, Quatraro A, Marchi E, Barbanti M, Lefebvre P. Ceriello A, et al. Diabetes. 1990 Apr;39(4):447-9. doi: 10.2337/diab.39.4.447. Diabetes. 1990. PMID: 2138576

6

Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans.

Ceriello A, Giugliano D, Quatraro A, Marchi E, Barbanti M, Lefèbvre P. Ceriello A, et al. Diabetologia. 1990 Mar;33(3):163-7. doi: 10.1007/BF00404044. Diabetologia. 1990. PMID: 2184068

7

Low molecular weight heparin restores antithrombin III activity from hyperglycemia induced alterations.

Ceriello A, Marchi E, Palazzni E, Quatraro A, Giugliano D. Ceriello A, et al. Diabete Metab. 1990 Mar-Apr;16(2):86-92. Diabete Metab. 1990. PMID: 2196192

8

Protein C deficiency in insulin-dependent diabetes: a hyperglycemia-related phenomenon.

Ceriello A, Quatraro A, Dello Russo P, Marchi E, Barbanti M, Milani MR, Giugliano D. Ceriello A, et al. Thromb Haemost. 1990 Aug 13;64(1):104-7. Thromb Haemost. 1990. PMID: 2274914

9

Increased alpha 2-macroglobulin in diabetes: a hyperglycemia related phenomenon associated with reduced antithrombin III activity.

Ceriello A, Giugliano D, Quatraro A, Stante A, Dello Russo P, Torella R. Ceriello A, et al. Acta Diabetol Lat. 1989 Apr-Jun;26(2):147-54. doi: 10.1007/BF02581366. Acta Diabetol Lat. 1989. PMID: 2476904

10

Hyperglycemia-conditioned increase in alpha-2-macroglobulin in healthy normal subjects: a phenomenon correlated with deficient antithrombin III activity.

Ceriello A, Quatraro A, Dello Russo P, Marchi E, Barbanti M, Giugliano D. Ceriello A, et al. Acta Haematol. 1989;82(2):61-3. doi: 10.1159/000205284. Acta Haematol. 1989. PMID: 2477983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

621 results

Search Page

Filters